Nov 04, 2020 / 11:30AM GMT
Operator
Ladies and gentlemen, good day, and welcome to the Jubilant Life Sciences Limited Earnings Conference Call for the quarter ended September 30, 2020. (Operator Instructions) Please note that this conference is being recorded.
I would now like to hand the conference over to Mr. Hemant Bakhru, Head, Investor Relations. Thank you, and over to you, Mr. Bakhru.
Hemant Bakhru -
Thanks. Good evening, everyone. I'm Hemant Bakhru, Head, Investor Relations, at Jubilant Life Sciences. Thank you for being on our Q2 FY '21 earnings conference call. I would like to remind you that some of the statements made on the call today could be forward-looking in nature, and a detailed disclaimer in this regard has been included in the press release that's also shared on our website.
On the call today, we have Mr. Shyam Bhartia, Chairman; Mr. Hari Bhartia, Co-Chairman and Managing Director; Mr. Pramod Yadav, CEO, Jubilant Pharma; Mr. Rajesh Srivastava, CEO, Life Science Ingredients; Mr. Syed Kazmi, CEO of Jubilant Therapeutics; and Mr. Arun Sharma, CFO, Jubilant Life Sciences
Q2 2021 Jubilant Life Sciences Ltd Earnings Call Transcript
Nov 04, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers